EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Liver Organoids: From Disease Modelling to Regenerative Medicine

Tiepeng Wang, Xiaotian Qu, Jinhong Si, Junkang Meng iD, Ting Zhang, Shuliang Niu

Cell Proliferation · 2026-11 · 59 (11)

DOI: 10.1111/cpr.70268 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cell Proliferation, online erschienen am 14.08.2026. Verfasst von Tiepeng Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Xinjiang Second Medical College, Karamay, Xinjiang, China. Hauptthemen laut MEDLINE: Organoids, Regenerative Medicine, Liver, Liver Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for Universities in Xinjiang, Karamay Key R&D Program Projects.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liver organoids are three‐dimensional miniature liver models that recapitulate the complex architecture and key functions of the human liver in vitro, offering powerful platforms for both fundamental research and translational applications. This review systematically summarises current fabrication strategies, disease‐modelling utilities and regenerative potentials of liver organoids, alongside the major challenges and future directions. In recent years, the field has witnessed several breakthroughs. Through endothelial co‐culture approaches, vascularised and metabolically zonated liver organoids have been successfully generated, achieving endothelial coverage exceeding 85%. Prime editing enables precise correction of pathogenic mutations in patient‐derived organoids, with no off‐target effects detected at the genome‐wide level. In disease modelling, iPSC‐derived liver organoids faithfully recapitulate the pathological progression of metabolic dysfunction‐associated steatotic liver disease (MASLD) and verify the lipid‐lowering efficacy of semaglutide. Macrophage‐integrated organoid models support the full life cycles of HEV, SARS‐CoV‐2 and dengue virus, providing new tools for antiviral drug screening. Large‐scale patient‐derived tumour organoid biobanks successfully preserve the heterogeneity and clinical drug‐resistance signatures of liver cancers. In regenerative medicine, encapsulated hepatocyte organoids and the UTOpiA bioartificial liver system have effectively rescued acute liver failure in animal models, while gene‐edited autologous organoids offer potential curative strategies for genetic disorders such as Wilson disease. Nevertheless, insufficient hepatocyte functional maturity, difficulties in constructing vascular networks, and the lack of standardised culture protocols remain major obstacles to clinical translation. By bridging fundamental liver biology and clinical practice, liver organoid technology lays a solid foundation for precision hepatology and regenerative therapies. Continued interdisciplinary efforts are still required to overcome current limitations and facilitate its clinical adoption.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OrganoidsRegenerative MedicineLiverLiver DiseasesHumansAnimalsModels, Biological

Stichwörter der Autor:innen

disease modellingdrug screeningliver organoidspluripotent stem cellsregenerative medicine

Autor:innen und Institutionen

  • Xinjiang Second Medical College, Karamay, Xinjiang, China.
  • Carver College of Medicine, the University of Iowa, Iowa City, Iowa, USA.
  • School of Medicine, Shihezi University, Shihezi, Xinjiang, China.

ORCID-Profile: Junkang Meng

Förderung

  • National Natural Science Foundation of China
  • Fundamental Research Funds for Universities in Xinjiang
  • Karamay Key R&D Program Projects
  • High-Level Talent Research Startup Program of Xinjiang Second Medical College
  • Xinjiang Second Med Coll Res Innov Team Program
  • Undergraduate Innovation and Entrepreneurship Training Program of Xinjiang Second Medical College

Zitieren

APA

Wang, T., Qu, X., Si, J., Meng, J., Zhang, T., & Niu, S. (2026). Liver Organoids: From Disease Modelling to Regenerative Medicine. Cell Proliferation, 59(11). https://doi.org/10.1111/cpr.70268

Vancouver

Wang T, Qu X, Si J, Meng J, Zhang T, Niu S. Liver Organoids: From Disease Modelling to Regenerative Medicine. Cell Proliferation. 2026;59(11). doi:10.1111/cpr.70268

BibTeX
@article{Wang2026,
  author = {Wang, Tiepeng and Qu, Xiaotian and Si, Jinhong and Meng, Junkang and Zhang, Ting and Niu, Shuliang},
  title = {Liver Organoids: From Disease Modelling to Regenerative Medicine},
  journal = {Cell Proliferation},
  year = {2026},
  volume = {59},
  number = {11},
  doi = {10.1111/cpr.70268}
}
Kostenlos starten →